Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine. (Q38335622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

0 references

personalized medicine

1 reference

based on heuristic

inferred from title

author

Javier Rodríguez-Carrio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Patricia López

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ana Suárez

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

449-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

Regulation of type I interferon responses

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferons in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The type I interferon system in the etiopathogenesis of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Overview of the biology of type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The interferon signature in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferonopathies: a novel set of inborn errors of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Links between type I interferons and the genetic basis of disease in mouse lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Genetic susceptibility to PolyI:C-induced IFNα/β-dependent accelerated disease in lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The emerging role of interferon in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Anti-inflammatory properties of Type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferon in organ-targeted autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Understanding IFNλ in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Associations between interferon regulatory factor 5 polymorphisms and rheumatoid arthritis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of the IRF5 rs2004640 polymorphism with rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Analysis ofIRF5 gene functional polymorphisms in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Autosome-wide copy number variation association analysis for rheumatoid arthritis using the WTCCC high-density SNP genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Variants Within STAT Genes Reveal Association with Anticitrullinated Protein Antibody-negative Rheumatoid Arthritis in 2 European Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Immune Interferon in the Circulation of Patients with Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Immunoreactive circulating alpha-interferon in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferon therapy and its role in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Syndromes and complications of interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Alpha-interferon-induced arthritis: clinical presentation treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Rheumatoid arthritis induced by alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Development of anti-CCP-positive rheumatoid arthritis following pegylated interferon-α2a treatment for chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Infectious agents in chronic rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Infection and musculoskeletal conditions: Viral causes of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Arthritogenic properties of double-stranded (viral) RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The Occurrence of Single-Stranded DNA in the Serum of Patients with Systemic Lupus Erythematosus and Other Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon-alpha: regulatory effects on cell cycle and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

How does interferon-α insult the vasculature? Let me count the ways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Evidence for the involvement of type I interferon in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association between IRF-5 polymorphisms and risk of acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Heart failure induced by non-cardiac drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferon-beta directly influences monocyte infiltration into the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140554

21 January 2018

Identifiers

DOI

10.1042/CS20140554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25630235%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference